These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7865123)

  • 41. Biologicals production by recombinant DNA technology in Cuba.
    Herrera L; Del la Fuente J; Quinones Y; Padron G; Agraz A; Vega J; Perez L; Silva A; Santizo C; Alvarez R
    Dev Biol Stand; 1989; 70():257-69. PubMed ID: 2503409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain.
    Morita M; Suzuki K; Yasuda A; Kojima A; Sugimoto M; Watanabe K; Kobayashi H; Kajima K; Hashizume S
    Vaccine; 1987 Mar; 5(1):65-70. PubMed ID: 3554809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic engineering applied to the development of vaccines.
    Murray K; Stahl S; Ashton-Rickardt PG
    Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):461-76. PubMed ID: 2573084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stability of recombinant vaccinia virus LC16m0 or LC16m8: preserved laboratory attenuation markers and conserved expression of inserted HBsAg gene.
    Watanabe K; Morita M; Kojima A
    Vaccine; 1989 Dec; 7(6):499-502. PubMed ID: 2609725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular biology of vaccinia virus and development of a new type of vaccine].
    Shida H
    Uirusu; 1986 Jun; 36(1):23-33. PubMed ID: 3535240
    [No Abstract]   [Full Text] [Related]  

  • 46. [Experimental study of residual virulence of viral vaccine strains].
    Makhlaĭ AA; Bektimirov TA; Borisevich SV; Mikhaĭlov VV; Perekrest VV; Podkuĭko VN; Kirillov VB; Levitov AT; Ruchko VM
    Vopr Virusol; 1999; 44(2):75-8. PubMed ID: 10358902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The vaccinia virus as a vector for genetically engineered vaccines and the study of viral protein functions].
    Vopr Virusol; 1986; 31(4):509-12. PubMed ID: 3464128
    [No Abstract]   [Full Text] [Related]  

  • 48. [Genome cloning of the vaccinia virus, Tiantan strain].
    Yang XK; Houg YD; Hu YW; Wu SH; Duan SM; Peng JZ; Li Y; Chang CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):394-7. PubMed ID: 6242537
    [No Abstract]   [Full Text] [Related]  

  • 49. Hybrid vaccinia virus for mass hepatitis immunization?
    Beale AJ
    Nature; 1983 Apr; 302(5908):476-7. PubMed ID: 6835381
    [No Abstract]   [Full Text] [Related]  

  • 50. [New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. a. Application of genetic engineering using Saccharomyces cerevisiae].
    Sakamoto S
    Nihon Rinsho; 1987 Oct; 45(10):2322-5. PubMed ID: 3329247
    [No Abstract]   [Full Text] [Related]  

  • 51. Recombinant vaccinia for prevention of hepatitis B.
    Beale J
    Nature; 1984 Sep 6-11; 311(5981):12-3. PubMed ID: 6472459
    [No Abstract]   [Full Text] [Related]  

  • 52. [Gene surgery: on the threshold of synthetic biology].
    Hobom B
    Med Klin; 1980 Nov; 75(24):834-41. PubMed ID: 6160378
    [No Abstract]   [Full Text] [Related]  

  • 53. [Genetic engineering and its applications].
    Belayew A; Martial J
    J Pharm Belg; 1984; 39(3):185-200. PubMed ID: 6148387
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetically engineered hepatitis B vaccine now available.
    CMAJ; 1987 Aug; 137(4):301. PubMed ID: 3607681
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetically engineered insect virus pesticides: present and future.
    Miller LK
    J Invertebr Pathol; 1995 May; 65(3):211-6. PubMed ID: 7745277
    [No Abstract]   [Full Text] [Related]  

  • 56. A new genetically engineered vaccine for animal growth promotion.
    Xu WZ; Du NX; Li GD; Wang Y; Li ZP
    Sci China B; 1994 Oct; 37(10):1234-41. PubMed ID: 7865123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction and evaluation of the eukaryotic expression plasmid encoding two copies of somatostatin genes fused with hepatitis B surface antigen gene S.
    Liang A; Cao S; Han L; Yao Y; Moaeen-Ud-Din M; Yang L
    Vaccine; 2008 Jun; 26(23):2935-41. PubMed ID: 18455280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous expression of growth hormone releasing hormone (GHRH) and hepatitis B surface antigen/somatostatin (HBsAg/SS) fusion genes in a construct in the skeletal muscle enhances rabbit weight gain.
    Dai JW; Liu SC; Hao LL; Zhang YL; Zhang Q; Ren XH; Jiang QY
    Anim Biotechnol; 2008; 19(2):104-16. PubMed ID: 18432401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.